secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHINA PHARMA HOLDINGS, INC. (CPHI)
CIK:        0001106644
Form:       8-K
Filed at:   2023-10-03T23:59:59+00:00
Accession:  0001013762-23-001101
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

NYSE American warns China Pharma of delisting; avg price below $0.20, cure by March 2024
--------------------------------------------------------------------------------

- On Sep 27, 2023, NYSE American notified CPHI of noncompliance: 30-day avg stock price below $0.20.
- Company must effect a reverse stock split or demonstrate sustained price improvement by Mar 27, 2024.
- Continues to address prior stockholders' equity noncompliance from June 2022.
- Listing remains on NYSE American during cure period; business operations unaffected.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1106644/000101376223001101/0001013762-23-001101-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1106644/000101376223001101/ea186256-8k_chinapharma.htm
  HTML page:      https://secwatch.observer/filing/0001013762-23-001101

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer